Latest Updates on Covid-19 Vaccine in India by Apollo 24|7

Q: When will I get the Covid vaccine?

There are international and Indian scientists and organizations that conducting Phase 3 of the Coronavirus Vaccine trials, and progress has been sped up. Apollo 24|7 Coronavirus vaccine progress tracker is keeping a close watch on Battleground Vaccine. At present, the best chances are with: 1.University of Oxford/AstraZeneca (UK) 2. Moderna/NIAID (USA) 3. BioNTech/Fosun Pharma/Pfizer (USA/Germany)

Q: How will I get the Covid vaccine?

Apollo Hospitals group is getting ready to administer 1 million vaccines a day. The group will leverage its robust pan-India web of 19 medicine supply hubs with cold chain facilities and use its 70 hospitals, 400+ clinics, 500 corporate health centers, 4,000 pharmacies alongside their omnichannel digital platform Apollo 24|7 to ensure massive administration capacity of COVID-19 vaccines. Stay with #BattlegroundVaccine we will keep you updated as we near the date of availability.

Q: What will be the possible price of the Covid vaccine in India?

Apollo24|7 will follow the government's directive on Coronavirus vaccine pricing. We will keep you updated on this as we have more information. It looks like the price would be at a point that makes it affordable for all.

INDIAN FRONT RUNNERS COVISHIELD by Oxford/Serum Institute In Phase 3 Trials Serum Institute is likely to be ready with 6-7 crore doses of the Oxford vaccine by Dec '20, but that will come to the market in 2021 after the clearance of licensing. COVAXIN by Bharat Biotech In Phase 1/ Phase 2 Trials Based on satisfactory results of its phase 1/2 clinical trials, Covaxin received approval for carrying out phase 3 trials. The vaccine is expected to be available by early 2021. NOVAVAX by Serum Institute In Phase 3 Trials Serum Institute will start trial of Novavax vaccine in India by Oct ’20, and will manufacture 100 crore doses of the vaccine for India and other low income countries in 2021. ZYDUS CADILA by Cadila Healthcare In Phase I/ Phase 2 Trials This DNA-based vaccine is currently in its phase 2 trials which began in early Aug '20. The trials are being conducted with over 1,000 healthy adults. TOP VACCINE CANDIDATES Oxford / AstraZeneca Type NON-REPLICATING VIRAL VECTOR The vaccine is currently in phase 3 clinical trials with 30,000 participants globally, the results of which are likely to be available by Nov/Dec '20 for review and approval. Country of Origin United Kingdom Pfizer / BioNTech Type RNA Shots to be taken: 2 Phase 3 trials is in progress with 43,000 participants and Pfizer will apply for emergency use in the US as soon as safety data is available, likely by the third week of Nov '20. Country of Origin: United States / Germany Moderna Inc / NIH Type RNA, Shots to be taken: 2 30,000 participants have enrolled for phase 3 trial, and more than 25,000 volunteers have received their second dose. Data from phase 3 clinical trials is expected by end of 2020. Country of Origin: United States Novavax Inc Type PROTEIN SUBUNIT Shots to be taken 2 Phase 3 trials began in Sep ‘20 on 10,000 volunteers in the UK, with a larger one planned in the US. If successful, 10 crore doses will be available in the US by early 2021. Country of Origin United States Gamaleya / Sputnik V Type NON-REPLICATING VIRAL VECTOR Shots to be taken 2 The vaccine is currently in phase 3 trials in Russia and other countries, with 40,000 people. In India, Dr. Reddy’s labs received approval to begin phase 2/3 trials in Oct '20. Country of Origin Russia J&J / Janssen Type NON-REPLICATING VIRAL VECTOR Shots to be taken 2 Phase 3 trials of the vaccine began in Sep '20 with 60,000 volunteers. The trials are currently on pause since 12 Oct '20 to probe an ‘unexplained sickness’ in a volunteer. Country of Origin United States Wuhan Institute / Sinopharm Type INACTIVATED Shots to be taken 2 Phase 3 clinical trials are being conducted in UAE, Peru, and Morocco. The vaccine was given an emergency approval by UAE in Sep '20 for use on healthcare workers. Country of Origin China Beijing Institute / Sinopharm Type INACTIVATED Shots to be taken 2 The UAE/Argentina are carrying out phase 3 trials of the vaccine after preliminary trials in China. The vaccine was approved for emergency use on healthcare workers. Country of Origin China Beijing Institute / CanSino Type NON-REPLICATING VIRAL VECTOR Shots to be taken 1 The vaccine is in phase 3 trials in Pakistan, Saudi Arabia, and Russia since Aug '20. It has also received emergency use authorization for the Chinese military. Country of Origin China Sinovac Biotech INACTIVATED Shots to be taken 2 The vaccine is undergoing phase 3 trials in multiple countries. In Jul '20, the Chinese government authorized its emergency use on high risk people and health workers. Country of Origin China APOLLO IS READY We're here and we're geared up. Apollo's network is powered with our chain of 4000+ pharmacies, 70+ hospitals, 7000+ doctors, and an impeccable digital network. We are capable of administering and storing 1 million vaccines with the help of a strong ecosystem. So India, we're ready for you. BATTLEGROUND VACCINE Let’s face it - the battle with the virus has been a tough one. The world is changing by the minute and developments on the vaccine are being made as we type this message. The next few weeks are crucial and we recommend you keep a close watch here. Something big maybe on its way.